Axtria driving growth from Basel
The US firm Axtria has established a new office in Basel. The company offers services for the life sciences industry in the field of cloud software and data analysis. Axtria is now planning to exploit the wealth of talent and specialists in the Basel Area to drive further growth.
Jaswinder Chadha, Co-Founder and CEO of Axtria (img: Axtria)
Founded in 2010, Axtria works with the 20 leading international life sciences firms, according to information from the company itself. Headquartered in the US state of New Jersey with a stronghold in India, the provider of cloud software and data analysis solutions aims to make decision-making processes easier for its clients by offering them the tools necessary for targeted research data analysis. To provide these services, Axtria relies on well-trained employees. This is just one of the reasons why the company has now decided on Basel as a new location. Basel Area Business & Innovation, the investment and innovation promotion agency, supported Axtria during the process of founding Axtria Swiss GmbH.
Axtria presently employs around 2,000 members of staff across the world. Of this number, 800 were only hired in 2020 alone. At the company headquarters in New Jersey, Axtria has been listed as one of the state’s 50 fastest-growing companies for seven successive years. “We are proud of our substantial growth within the market, and our investments within the company reflect our commitment to continue that progress”, comments Jaswinder Chadha, co-founder and CEO of Axtria. Chadha goes on to describe Europe and the USA as the company’s most important markets. With the opening of new offices, Axtria employees will be in a position to “make an impact in the life sciences industry”.
In this context, the company also underlines that its Basel office is part of a long-term corporate strategy that aims to operate in close proximity to its customers. Basel is, after all, home to numerous companies active in the field of life sciences. Moreover, Axtria’s growth will be advanced by well-trained employees. For this reason, Basel is a prime location for the company from which it can implement plans to drive both sales and therefore growth as well.
Share this article
You may also be interested in
Noema Pharma raises 103 million Swiss francs from investors
Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....Read More
Basel still the most attractive small city for business in Europe
As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...Read More
Ariceum Therapeutics establishes subsidiary in Basel
The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...Read More
RocketVax raises fresh capital
The Basel-based biotech startup RocketVax has successfully closed another financing round. This additional funding will primarily be used to further...Read More
Clinerion is now part of Citeline
Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...Read More
KUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...Read More